
PMC:7299399 / 14629-15526
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T62 | 607-615 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T88 | 104-109 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T89 | 203-218 | Chemical | denotes | antiviral drugs | http://purl.obolibrary.org/obo/CHEBI_36044 |
T90 | 203-212 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T91 | 213-218 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T92 | 334-343 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T93 | 344-347 | Chemical | denotes | NPs | http://purl.obolibrary.org/obo/CHEBI_50803 |
T94 | 380-393 | Chemical | denotes | cyclodextrins | http://purl.obolibrary.org/obo/CHEBI_23456 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T69 | 169-265 | Sentence | denotes | For these reasons, when designing antiviral drugs, clearance mechanisms have to be kept in mind. |
T70 | 266-788 | Sentence | denotes | An example of this process is the recent redesign of broad-spectrum antiviral NPs into equally effective modified cyclodextrins.54 Moreover, nanotechnology may offer nanotheranostic approaches to fill the existing gap between diagnostics and therapy.55−57 The simultaneous management of both diagnostics and therapy for those suffering from COVID-19 or in future pandemics, as for many other diseases, is an additional potential strategy to take into consideration in which nanomaterials have proven to be effective tools. |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
242 | 56-64 | Species | denotes | patients | Tax:9606 |
243 | 380-393 | Chemical | denotes | cyclodextrins | MESH:D003505 |
244 | 34-42 | Disease | denotes | toxicity | MESH:D064420 |
245 | 607-615 | Disease | denotes | COVID-19 | MESH:C000657245 |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32519842-32064341-158481 | 394-396 | 32064341 | denotes | 54 |
32519842-32031781-158482 | 516-518 | 32031781 | denotes | 55 |
32519842-32373222-158483 | 519-521 | 32373222 | denotes | 57 |